Theravance slips after setback for ampreloxetine in second Phase 3 hypotension trial
05 April 2022 - 6:27AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Theravance Biopharma (NASDAQ:TBPH)
Historical Stock Chart
From Apr 2024 to May 2024
Theravance Biopharma (NASDAQ:TBPH)
Historical Stock Chart
From May 2023 to May 2024